TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
UPB

Upstream Bio, Inc.

Healthcare · Biotechnology · —

5.30$ +0.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement UPB
Line item 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0%
0.6% 2.5% 3.8% 6.6%
100.0% 100.0% 100.0% 100.0%
1,539.4% 1,336.1% 2,656.8% 4,793.5%
533.3% 449.4% 724.4% 925.3%
2,072.7% 1,785.5% 3,381.2% 5,718.8%
-1,972.7% -1,685.5% -3,281.2% -5,618.8%
-1,969.3% -862.9% -2,650.0% -5,026.0%
-1,969.3% -862.9% -2,650.0% -5,026.0%
-1,968.7% -860.4% -2,646.3% -5,019.4%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?